These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 72116)

  • 1. Specific, immunologic regulation of differentiation of immunoglobulin expression in MOPC-315 cells during in vivo growth in diffusion chambers.
    Rohrer JW; Lynch RG
    J Immunol; 1977 Dec; 119(6):2045-53. PubMed ID: 72116
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigen-specific regulation of myeloma cell differentiation in vivo by carrier-specific T cell factors and macrophages.
    Rohrer JW; Lynch RG
    J Immunol; 1978 Sep; 121(3):1066-74. PubMed ID: 80422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloma cell immunoglobulin expression during in vivo growth in diffusion chambers: evidence for repetitive cycles of differentiation.
    Rohrer JW; Vasa K; Lynch RG
    J Immunol; 1977 Sep; 119(3):861-6. PubMed ID: 330758
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoregulation of murine myeloma: isologous immunization with M315 induces idiotype-specific T cells that suppress IgA secretion by MOPC-315 cells in vivo.
    Rohrer JW; Odermatt B; Lynch RG
    J Immunol; 1979 May; 122(5):2011-9. PubMed ID: 87450
    [No Abstract]   [Full Text] [Related]  

  • 5. Idiotype-specific suppression of MOPC-315 IgA secretion in vivo: reversible blockade of secretory myeloma cells by soluble mediators.
    Rohrer JW; Odermatt B; Lynch RG
    J Immunol; 1978 Nov; 121(5):1799-807. PubMed ID: 712066
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of myeloma growth in vitro by idiotype-specific T lymphocytes.
    Flood PM; Philipps C; Taupier MA; Schreiber H
    J Immunol; 1980 Jan; 124(1):424-30. PubMed ID: 6965296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulation of localized and disseminated murine myeloma: antigen-specific regulation of MOPC-315 stem cell proliferation and secretory cell differentiation.
    Rohrer JW; Lynch RG
    J Immunol; 1979 Sep; 123(3):1083-7. PubMed ID: 89159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte surface membrane immunoglobulin in myeloma. II. T cells with IgA-Fc receptors are markedly increased in mice with IgA plasmacytomas.
    Hoover RG; Lynch RG
    J Immunol; 1980 Sep; 125(3):1280-8. PubMed ID: 6967897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model of B cell differentiation.
    Lynch RG; Rohrer JW; Odermatt B; Gebel HM; Autry JR; Hoover RG
    Immunol Rev; 1979; 48():45-80. PubMed ID: 94898
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocyte surface membrane immunoglobulin in myeloma. I. M315-bearing T lymphocytes in mice with MOPC-315.
    Gebel HM; Hoover RG; Lynch RG
    J Immunol; 1979 Sep; 123(3):1110-6. PubMed ID: 313945
    [No Abstract]   [Full Text] [Related]  

  • 11. Idiotype-specific T cell immunity. I. Generation of effector and suppressor T lymphocytes reactive with myeloma idiotypic determinants.
    Abbas AK; Perry LL; Bach BA; Greene MI
    J Immunol; 1980 Mar; 124(3):1160-6. PubMed ID: 6153672
    [No Abstract]   [Full Text] [Related]  

  • 12. Absence of an antigen-specific helper T cell required for the expression of the T 15 idiotype in mice treated with anti-mu antibody.
    Bottomly K; Janeway CA; Mathieson BJ; Mosier DE
    Eur J Immunol; 1980 Feb; 10(2):159-63. PubMed ID: 6154584
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of immune response to sheep red blood cells on plasmacytoma MOPC 104 E.
    Ghanta VK; Hiramoto NS; Hiramoto RN
    Cancer Res; 1981 Jun; 41(6):2197-9. PubMed ID: 7237419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observations of IgG1 anti-DNP hybridoma-mediated ADCC and the failure of three IgM anti-DNP hybridomas to mediate ADCC.
    Greenberg AH; Lydyard PM
    J Immunol; 1979 Aug; 123(2):861-9. PubMed ID: 458155
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro and in vivo studies of a 2,4,6-trinitrophenyl (TNP)-binding immunoglobulin A (IgA) lymphoma isolated from MOPC-315, a TNP-binding IgA plasmacytoma of BALB/c mice.
    Gebel HM; Autry JR; Rohrer JW; Lynch RG
    J Natl Cancer Inst; 1979 Jan; 62(1):201-11. PubMed ID: 281574
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of growth of MOPC 104E cells in immunosuppressed mice.
    Hiramoto RN; Cox PJ; Hiramoto NS; Ghanta VK
    J Immunol; 1984 Dec; 133(6):3424-8. PubMed ID: 6386985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on hapten-specific B cell tolerance in vitro. II. Regulation of central tolerance in T-independent B cells by antigen-activated syngeneic T cells.
    Chen S; Cerny J
    J Immunol; 1980 Nov; 125(5):1970-6. PubMed ID: 6776185
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
    Fenton MR; Havas HF
    J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-expression of nonglycosylated surface IgA in trypsin-treated MOPC 315 plasmacytoma cells.
    Hickman S; Wong-Yip YP
    J Immunol; 1979 Jul; 123(1):389-95. PubMed ID: 448154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloma-induced immunosuppression: a multistep mechanism.
    Katzmann JA
    J Immunol; 1978 Oct; 121(4):1405-9. PubMed ID: 701801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.